BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2884140)

  • 1. Clinical evaluation of steroid receptors in ovarian neoplasms.
    Agarwal N; Rao DL; Murgeshan K; Verma U; Mittal S; Buckshee K; Chapeker TN
    Int J Gynaecol Obstet; 1987 Apr; 25(2):145-9. PubMed ID: 2884140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Estrogen and progesterone receptor systems of the endometrium in benign tumors of the uterus and ovary].
    Fanchenko ND; Adamian LV; Minina LS; Khel'mund K
    Akush Ginekol (Mosk); 1987 Jul; (7):26-8. PubMed ID: 3688324
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytoplasmic steroid receptors in ovarian tumours.
    Quinn MA; Pearce P; Rome R; Funder JW; Fortune D; Pepperell RJ
    Br J Obstet Gynaecol; 1982 Sep; 89(9):754-9. PubMed ID: 7115640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cytoplasmatic receptors of steroid hormones in malignant epithelial ovarian tumors].
    Makhova EE; Gershteĭn ES; Smirnova KD; Murav'eva NI; Kuz'mina ZV
    Vopr Onkol; 1984; 30(12):36-40. PubMed ID: 6516272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen and progesterone receptors in human ovarian tumors.
    Willcocks D; Toppila M; Hudson CN; Tyler JP; Baird PJ; Eastman CJ
    Gynecol Oncol; 1983 Oct; 16(2):246-53. PubMed ID: 6313494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid receptor content in human ovarian tumors: survival of patients with ovarian carcinoma related to steroid receptor content.
    Iversen OE; Skaarland E; Utaaker E
    Gynecol Oncol; 1986 Jan; 23(1):65-76. PubMed ID: 3943754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cytosol receptor levels in malignant and benign ovarian tumors].
    Thurzó L; Falkay G; Sas M
    Orv Hetil; 1987 Aug; 128(36):1881-4, 1887. PubMed ID: 3658406
    [No Abstract]   [Full Text] [Related]  

  • 8. [Steroid hormone receptors in ovarian carcinomas and their clinical significance].
    Geyer H; Teufel G; de Gregorio G; Pfleiderer A
    Onkologie; 1984 May; 7 Suppl 2():44-52. PubMed ID: 6379538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen and progesterone receptor titers in primary epithelial ovarian carcinomas.
    Jones LA; Edwards CL; Freedman RS; Tan MT; Gallager HS
    Int J Cancer; 1983 Nov; 32(5):567-71. PubMed ID: 6315602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen and progesterone receptors in ovarian neoplasms.
    Ford LC; Berek JS; Lagasse LD; Hacker NF; Heins Y; Esmailian F; Leuchter RS; DeLange RJ
    Gynecol Oncol; 1983 Jun; 15(3):299-304. PubMed ID: 6862289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of estrogen and progesterone receptors in epithelial ovarian cancer.
    Rose PG; Reale FR; Longcope C; Hunter RE
    Obstet Gynecol; 1990 Aug; 76(2):258-63. PubMed ID: 2371031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Estrogen and progesterone receptors in human ovary and ovarian tumors].
    Han SW; Cao ZY; He B; Wang JH; Chen ML
    Hua Xi Yi Ke Da Xue Xue Bao; 1989 Sep; 20(3):253-6. PubMed ID: 2625328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of estrogen and progestin receptors in ovarian cancer.
    Kauppila A; Vierikko P; Kivinen S; Stenbäck F; Vihko R
    Obstet Gynecol; 1983 Mar; 61(3):320-6. PubMed ID: 6823373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroid receptors in human ovarian malignancy. A review of four years tissue collection.
    Toppila M; Tyler JP; Fay R; Baird PJ; Crandon AJ; Eastman CJ; Hudson CN
    Br J Obstet Gynaecol; 1986 Sep; 93(9):986-92. PubMed ID: 3768292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of estrogen and progesterone cytosol receptor concentration in benign and malignant ovarian tumors and a review of malignant ovarian tumors treated with medroxy-progesterone acetate.
    Bergqvist A; Kullander S; Thorell J
    Acta Obstet Gynecol Scand Suppl; 1981; 101():75-81. PubMed ID: 6946676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are cytosol estrogen and progestin receptors of prognostic significance in the management of epithelial ovarian cancers?
    Schwartz PE; MacLusky N; Merino MJ; Livolsi VA; Kohorn EI; Eisenfeld A
    Obstet Gynecol; 1986 Dec; 68(6):751-8. PubMed ID: 3785785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of cytosol estrogen and progestin receptor status in malignant and benign tumors and tumor-like lesions of human ovary.
    Jänne O; Kauppila A; Syrjälä P; Vihko R
    Int J Cancer; 1980 Feb; 25(2):175-9. PubMed ID: 7390646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Estrogen and progesterone receptors in malignant ovarian neoplasms].
    Teufel G; Geyer H; de Gregorio G; Fuchs A; Kleine W; Pfleiderer A
    Geburtshilfe Frauenheilkd; 1983 Dec; 43(12):732-40. PubMed ID: 6559148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ovarian tumor and steroid hormone receptors].
    Nishimura H; Yakushiji M; Miyoshi T; Tashiro M; Yamada T; Tomoo Y; Kato T
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Apr; 37(4):665-8. PubMed ID: 2985720
    [No Abstract]   [Full Text] [Related]  

  • 20. [Estrogen and progesterone receptors in ovarian carcinoma].
    Kanajet D; Klarić P; Bolf-Benković L
    Jugosl Ginekol Perinatol; 1985; 25(1-2):13-6. PubMed ID: 3003465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.